Dr. Carl June is seeking to take the cancer-fighting cell therapy he developed more than a dozen years ago at the University of Pennsylvania to the next level. Penn ...
This year will be regarded as an inflection point for the treatment of glioblastoma, a rare and aggressive form of brain cancer that carries a median survival time of around 15 to 18 months, said Carl ...
Dr. Carl June and Bruce Levine will share the $400,000 prize with Isabelle Rivière and Michel Sadelain, formerly of Memorial Sloan Kettering Cancer Center in New York. Penn names permanent medical ...
Perelman School of Medicine professor Carl June at the flash mob celebration for the FDA approval of the CAR T cell therapy he developed, in August 2017 (Photo courtesy of Penn Medicine). Perelman ...